Category Archives: Healthcare

Monday’s Midday Stock Update: TG Therapeutics (TGTX), Calumet Specialty Products (CLMT), Aerie Pharma (AERI), United States Steel (X), Organovo Holdings (ONVO)

So far Monday, August 2, NASDAQ is down -0.08% and the S&P is down -1.64%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; TG Therapeutics (TGTX – Research Report), Calumet Specialty Products (CLMT

Mizuho Securities Thinks Autolus Therapeutics’ Stock is Going to Recover

In a report released today, Mara Goldstein from Mizuho Securities maintained a Buy rating on Autolus Therapeutics (AUTL – Research Report), with a price target of $18.00. The company’s shares closed last Friday at $5.32, close to its 52-week low

H.C. Wainwright Thinks AzurRx BioPharma’s Stock is Going to Recover

In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on AzurRx BioPharma (AZRX – Research Report), with a price target of $2.00. The company’s shares closed last Friday at $0.54, close to its 52-week low

Intercept Pharma (ICPT) Gets a Hold Rating from H.C. Wainwright

In a report released today, Ed Arce from H.C. Wainwright maintained a Hold rating on Intercept Pharma (ICPT – Research Report), with a price target of $18.00. The company’s shares closed last Friday at $17.28, close to its 52-week low

Analysts Offer Insights on Healthcare Companies: Regeneron (NASDAQ: REGN), Argenx Se (NASDAQ: ARGX) and BioNTech SE (NASDAQ: BNTX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Regeneron (REGN – Research Report), Argenx Se (ARGX – Research Report) and BioNTech SE (BNTX – Research Report) with bullish sentiments. Regeneron

Leerink Partners Reaffirms Their Buy Rating on Bluebird Bio (BLUE)

In a report issued on July 28, Mani Foroohar from Leerink Partners maintained a Buy rating on Bluebird Bio (BLUE – Research Report). The company’s shares closed last Friday at $25.41, close to its 52-week low of $24.24. According to